These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9500362)

  • 41. Pertussis vaccine and neurologic disease.
    Kumar ML; Mortimer EA
    Pediatrics; 1985 Mar; 75(3):617. PubMed ID: 3975139
    [No Abstract]   [Full Text] [Related]  

  • 42. Public health. The pertussis paradox.
    Allen A
    Science; 2013 Aug; 341(6145):454-5. PubMed ID: 23908204
    [No Abstract]   [Full Text] [Related]  

  • 43. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of whole-cell pertussis vaccine in severe local reactions to the preschool (fifth) dose of diphtheria-pertussis-tetanus vaccine.
    Scheifele DW; Bjornson G; Halperin SH; Mitchell L; Boraston S
    CMAJ; 1994 Jan; 150(1):29-35. PubMed ID: 8275406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reactogenicity of fluid compared with adsorbed diphtheria-pertussis-tetanus vaccine.
    Mathias RG
    Can Med Assoc J; 1984 Jun; 130(12):1561-5. PubMed ID: 6610469
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overview of currently available Japanese acellular pertussis vaccines and future problems.
    Kamiya H; Nii R
    Tokai J Exp Clin Med; 1988; 13 Suppl():45-9. PubMed ID: 3273618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acellular pertussis vaccines pertinent issues.
    Mathew JL
    Indian Pediatr; 2008 Sep; 45(9):727-9. PubMed ID: 18820375
    [No Abstract]   [Full Text] [Related]  

  • 48. Pertussis vaccine--time to stop the confusion.
    Burgess MA
    Med J Aust; 1994 Sep; 161(5):293-4. PubMed ID: 7830662
    [No Abstract]   [Full Text] [Related]  

  • 49. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.
    Gustafsson L; Hallander HO; Olin P; Reizenstein E; Storsaeter J
    N Engl J Med; 1996 Feb; 334(6):349-55. PubMed ID: 8538705
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Issues about pertussis vaccines.
    Miller E; Eskola J
    Lancet; 1998 Feb; 351(9103):677-8; author reply 678-9. PubMed ID: 9500361
    [No Abstract]   [Full Text] [Related]  

  • 51. [New pertussis vaccines are tested].
    Hallander H; Wigzell H; Gothefors L; Olin P; Trollfors B
    Lakartidningen; 1992 Nov; 89(45):3820-2, 3825. PubMed ID: 1460993
    [No Abstract]   [Full Text] [Related]  

  • 52. [Compare pertussis vaccines--but do it accurately].
    Olin P; Hallander HO
    Lakartidningen; 1996 Feb; 93(7):603-4. PubMed ID: 8642927
    [No Abstract]   [Full Text] [Related]  

  • 53. [Protective effect of 2 acellular pertussis vaccines in a double-blind placebo controlled clinical trial].
    Kallings LO; Olin P; Storsaeter J
    Lakartidningen; 1988 Jun; 85(22):1994-6. PubMed ID: 3287070
    [No Abstract]   [Full Text] [Related]  

  • 54. Issues about pertussis vaccines.
    Hurley S; Bennet J; Gust I
    Lancet; 1998 Feb; 351(9103):678; author reply 678-9. PubMed ID: 9500362
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.